Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1998 Nov;74(877):685–687. doi: 10.1136/pgmj.74.877.685

Orthostatic hypotension in an elderly patient.

L Allcock 1, C Polack 1, D O'Shea 1, P McKenna 1, D O'Shea 1
PMCID: PMC2431608  PMID: 10197220

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briggs M. H., Briggs M. Glucocorticoid properties of progestogens. Steroids. 1973 Oct;22(4):555–559. doi: 10.1016/0039-128x(73)90011-1. [DOI] [PubMed] [Google Scholar]
  2. CAMANNI F., MASSARA F., MOLINATTI G. M. THE CORTISONE-LIKE EFFECT OF 6ALPHA-METHYL-17ALPHA-ACETOXYPROGESTERONE IN THE ADRENALECTOMIZED MAN. Acta Endocrinol (Copenh) 1963 Aug;43:477–483. [PubMed] [Google Scholar]
  3. Donckier J. E., Michel L. A., Buysschaert M. Cushing syndrome and medroxyprogesterone acetate. Lancet. 1990 May 5;335(8697):1094–1094. doi: 10.1016/0140-6736(90)92663-3. [DOI] [PubMed] [Google Scholar]
  4. Grenfell A., Rudenski A., Watts M., Wiltshire C., Day J. L., Gray I. P. Cushing's syndrome and medroxyprogesterone acetate. Lancet. 1990 Jul 28;336(8709):256–256. doi: 10.1016/0140-6736(90)91789-d. [DOI] [PubMed] [Google Scholar]
  5. Leinung M. C., Liporace R., Miller C. H. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med. 1995 Jun 1;122(11):843–845. doi: 10.7326/0003-4819-122-11-199506010-00006. [DOI] [PubMed] [Google Scholar]
  6. Loprinzi C. L., Jensen M. D., Jiang N. S., Schaid D. J. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc. 1992 Dec;67(12):1160–1162. doi: 10.1016/s0025-6196(12)61145-8. [DOI] [PubMed] [Google Scholar]
  7. Lundblad J. R., Roberts J. L. Regulation of proopiomelanocortin gene expression in pituitary. Endocr Rev. 1988 Feb;9(1):135–158. doi: 10.1210/edrv-9-1-135. [DOI] [PubMed] [Google Scholar]
  8. Malik K. J., Wakelin K., Dean S., Cove D. H., Wood P. J. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate. Ann Clin Biochem. 1996 May;33(Pt 3):187–189. doi: 10.1177/000456329603300302. [DOI] [PubMed] [Google Scholar]
  9. Muss H. B., Cruz J. M. High-dose progestin therapy for metastatic breast cancer. Ann Oncol. 1992 Aug;3 (Suppl 3):15–20. doi: 10.1093/annonc/3.suppl_3.s15. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES